HealthCor Partners
HealthCor Partners Management, L.P. (HealthCor Partners), is a registered investment advisor with the U.S. Securities and Exchange
Business Model:
Revenue: $10.4M
Employees: 51-200
Rankings
Industries / Tags:
Detailed HealthCor Partners Information
Geographic Data
Address: 701 E Bay Street
City: Charleston
State: SC
Zip: 29403
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$1B
Social
Twitter
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
HealthCor Partners Management, L.P. ("HealthCor Partners"), is a registered investment advisor with the U.S. Securities and Exchange Commission (the “SEC”). Together with its affiliate, HealthCor Partners has approximately $365 million of capital commitments dedicated to private equity investments. HealthCor Partners invests primarily in growth equity and later stage developmental companies across all sectors of the healthcare and life sciences industry.
Contact Phone:
+12126227800
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2008 | Paradigm Spine | Series E | 25M |
| 1/2022 | DNA Script | Series C | 0 |
| 9/2010 | Sadra Medical | Venture Round | 4M |
| 6/2008 | ApaTech | Venture Round | 45M |
| 10/2017 | Claret Medical | Series C | 0 |
| 4/2023 | HeartFlow | Series F | 0 |
| 2/2007 | Paradigm Spine | Series D | 13.9M |
| 4/2008 | Corindus | Series B | 0 |
| 10/2015 | PreemaTEX | Venture Round | - |
| 12/2022 | Karyopharm Therapeutics | Post-IPO Equity | 0 |
| 1/2021 | Ikena Oncology | Series B | 0 |
| 7/2021 | Imperative Care | Series D | 0 |
| 8/2015 | ReShape Lifesciences | Post-IPO Equity | 38M |
| 1/2008 | HeartFlow | Seed Round | - |
| 8/2015 | HLS Therapeutics | Equity | 30M |
| 4/2015 | Natera | Series F | 0 |
| 3/2010 | Access Closure | Venture Round | 10M |
| 6/2022 | Mineralys Therapeutics | Series B | 0 |
| 7/2013 | KellBenx | Series C | 10M |
| 11/2021 | Acrivon Therapeutics | Series B | 0 |
| 4/2011 | CareView Communications | Post-IPO Debt | 20M |
| 6/2022 | Mineralys Therapeutics | Series B | 0 |
| 1/2022 | DNA Script | Series C | 0 |
| 11/2021 | Acrivon Therapeutics | Series B | 0 |
| 7/2021 | Imperative Care | Series D | 0 |
| 1/2021 | Ikena Oncology | Series B | 0 |
| 10/2017 | Claret Medical | Series C | 0 |
| 10/2015 | PreemaTEX | Venture Round | - |
| 8/2015 | HLS Therapeutics | Venture Round | 0 |
| 8/2015 | ReShape Lifesciences | Post-IPO Equity | 0 |
| 4/2015 | Natera | Series F | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
